期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
牡蛎肽通过NF-κB/iNOS信号通路改善肝纤维化 被引量:1
1
作者 邓凯翔 彭经宙 +6 位作者 张美泉 林慧娟 王小华 何道兴 朱俊明 陈明光 黄津 《Journal of Chinese Pharmaceutical Sciences》 CAS CSCD 2023年第6期435-445,共11页
本文研究探讨牡蛎肽(OP)改善肝纤维化的机制可能是通过NF-κB/iNOS信号通路。将50只雄性SD大鼠采用随机数字表法随机分为5组:对照组、模型组、低剂量(0.5 g/kg) OP组、中剂量(1.0 g/kg) OP组、高剂量(2.0 g/kg) OP组,每组10只。皮下注射... 本文研究探讨牡蛎肽(OP)改善肝纤维化的机制可能是通过NF-κB/iNOS信号通路。将50只雄性SD大鼠采用随机数字表法随机分为5组:对照组、模型组、低剂量(0.5 g/kg) OP组、中剂量(1.0 g/kg) OP组、高剂量(2.0 g/kg) OP组,每组10只。皮下注射50%四氯化碳(CCl4)建立肝纤维化大鼠模型6周。结果发现,OP治疗组中,CCl4诱导的肝纤维化大鼠肝脏中Ⅰ型胶原、Ⅲ型胶原和TGF-β1表达水平均显著低于模型组(P<0.05)。OP可以下调大鼠的肝组织NF-κB和iNOS的表达,可能是通过介导NF-κB/iNOS信号通路改善大鼠肝纤维化。 展开更多
关键词 肝纤维化 牡蛎肽 核因子-ΚB 诱导型一氧化氮合酶
原文传递
The pharmacological mechanism underlying the apoptosis of human hepatic stellate cells LX-2 induced by NF-κB inhibitor PDTC 被引量:1
2
作者 Jin Huang Kaixiang Deng +4 位作者 Meizhen Huang Gaomin Lin Mei Lin Shuimei Lian meiquan zhang 《Journal of Chinese Pharmaceutical Sciences》 CAS CSCD 2022年第9期665-676,共12页
In the present study,we aimed to confirm whether NF-κB inhibitor pyrrolidine dithiocarbamate(PDTC)could induce apoptosis of human hepatic stellate cells(HSCs)LX-2 and explore the potential pharmacological mechanism u... In the present study,we aimed to confirm whether NF-κB inhibitor pyrrolidine dithiocarbamate(PDTC)could induce apoptosis of human hepatic stellate cells(HSCs)LX-2 and explore the potential pharmacological mechanism underlying these effects.In this study,LX-2 cells were cultured in vitro,and the experiment was divided into two groups,including the control and PDTC groups.The viability of LX-2 cells was measured by CCK8 assay after the cells were exposed to PDTC.The anti-apoptotic effect of PDTC was detected by AO/EB double assay staining kit.Additionally,the activities of NF-κB,Fas/FasL,apoptosis-related proteins,as well as the cellular localization of AIF,were determined by Western blotting analysis and immunofluorescence staining respectively.After PDTC treatment for 12 and 24 h,AO/EB dual staining showed typical apoptotic changes,such as cell volume reduction,cell shrinkage,nuclear fragmentation,and so on.PDTC at 60μmol/L significantly increased the proliferation inhibition rate and decreased the secretion of collagen I,collagen III,andα-SMA in LX-2 cells.The Western blotting analysis and RT-PCR showed no significant difference in the expression of AIF between the control group and PDTC group,and the expressions of Fas and FasL were not observed in all groups(P>0.05).Further results showed that PDTC could promote the displacement of AIF from mitochondria to the nucleus,activate the apoptotic signaling in the cell nucleus,and possibly participate in the apoptosis process of LX-2 cells.In conclusion,the pharmacological mechanism of PDTC against hepatic fibrosis might be to promote the displacement of AIF from mitochondria to the nucleus,then activate the apoptotic signaling in the cell nucleus,and finally induce the apoptosis of LX-2 cells.Meanwhile,these results also revealed that the Fas/FasL-mediated apoptosis pathway was not involved in the PDTC-induced apoptosis process of LX-2 cells. 展开更多
关键词 Hepatic fibrosis LX-2 FAS/FASL AIF Pyrrolidine dithiocarbamate
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部